This statistic shows the quarterly biotechnology IPO pricing in the United States from 2014 to 2016, sorted by the expected price range. In the second quarter of 2015, 27 percent of IPO prices were below their expected range.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
EY. (June 29, 2017). Quarterly biotechnology IPO pricing in the United States from 2014 to 2016 [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 23, 2026, from /statistics/440976/us-biotechnology-ipo-pricing-by-quarter/
EY. "Quarterly biotechnology IPO pricing in the United States from 2014 to 2016." Chart. June 29, 2017. ÌÇÐÄÆƽâ°æ. Accessed July 23, 2026. /statistics/440976/us-biotechnology-ipo-pricing-by-quarter/
EY. (2017). Quarterly biotechnology IPO pricing in the United States from 2014 to 2016. ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 23, 2026. /statistics/440976/us-biotechnology-ipo-pricing-by-quarter/
EY. "Quarterly Biotechnology Ipo Pricing in The United States from 2014 to 2016." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 29 Jun 2017, /statistics/440976/us-biotechnology-ipo-pricing-by-quarter/
EY, Quarterly biotechnology IPO pricing in the United States from 2014 to 2016 ÌÇÐÄÆƽâ°æ, /statistics/440976/us-biotechnology-ipo-pricing-by-quarter/ (last visited July 23, 2026)
Quarterly biotechnology IPO pricing in the United States from 2014 to 2016 [Graph], EY, June 29, 2017. [Online]. Available: /statistics/440976/us-biotechnology-ipo-pricing-by-quarter/
